Clinical evaluation of Talapotaka Churna – A polyherbal Ayurvedic formulation in type 2 Diabetes mellitus

Abstract

To evaluate and compare the antidiabetic effect of Talapotaka Churna in Type II Diabetes mellitus patients were registered from S. S. Hospital, Banaras Hindu University, Varanasi. Patients were randomly divided in four groups for treatment of four different medicine groups: [Group A- Talapotaka Churna (4 g TID) with Takra (Buttermilk) before meal; Group B- Talapotaka Churna (4 g TID) with warm water before meal; Group C- Talapotaka Churna (4 g TID) with ongoing allopathic treatment with water before meal. Group D- Glimepride treated (1 mg BD) before meal]. The treatment was given for a period of two months. Fasting blood sugar, postprandial blood sugar, HbA1c, SGOT, SGPT, Sr. Creatinine and lipid profile level were estimated biochemically. The results were promising and reveal that Talapotaka Churna can be a safe, acceptable and effective alternative or adjuvant to the conventional oral hypoglycemic agents. Holistic principles of Ayurveda when used as supplementary for modern drugs in diabetes show their effects on all bodily symptoms and helps to minimize them in which modern drug fails. So, it is the need of time to support the modern medications with Ayurvedic therapy. © 2018, National Institute of Science Communication and Information Resources (NISCAIR). All rights reserved.